Ascendis Pharma A/S
Hedge Funds Holdings
Last updated:
Ascendis Pharma A/S‘s stocks are currently a part of 171 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 61.95M shares of Ascendis Pharma A/S. Compared to the previous quarter, the number grew by 6.14% or 3.58M shares more. As for the holding position changes, 36.84% (63) of current hedge fund investors increased the number of shares held, 34.5% (59) of current holders sold a part of the shares held, and 14.62% (25) closed the holdings completely. 26 hedge funds are new holders of Ascendis Pharma A/S stock in Q1 2022, it is 15.2% of total holders.
Hedge funds holding Ascendis Pharma A/S (Q2 2017 – Q1 2022)
| Q2 2017 | 34 |
|---|---|
| Q3 2017 | 59 |
| Q4 2017 | 65 |
| Q1 2018 | 89 |
| Q2 2018 | 100 |
| Q3 2018 | 95 |
| Q4 2018 | 103 |
| Q1 2019 | 139 |
| Q2 2019 | 133 |
| Q3 2019 | 129 |
| Q4 2019 | 142 |
| Q1 2020 | 145 |
| Q2 2020 | 152 |
| Q3 2020 | 151 |
| Q4 2020 | 171 |
| Q1 2021 | 172 |
| Q2 2021 | 166 |
| Q3 2021 | 163 |
| Q4 2021 | 171 |
| Q1 2022 | 171 |
Hedge funds changes in Ascendis Pharma A/S positions (Q2 2017 – Q1 2022)
| Q2 2017 | 6 | 15 | 7 | 6 | 0 |
|---|---|---|---|---|---|
| Q3 2017 | 27 | 21 | 6 | 2 | 3 |
| Q4 2017 | 19 | 21 | 14 | 13 | -2 |
| Q1 2018 | 33 | 27 | 24 | 9 | -4 |
| Q2 2018 | 19 | 37 | 29 | 8 | 7 |
| Q3 2018 | 10 | 39 | 29 | 15 | 2 |
| Q4 2018 | 18 | 30 | 40 | 10 | 5 |
| Q1 2019 | 49 | 41 | 42 | 13 | -6 |
| Q2 2019 | 19 | 57 | 42 | 24 | -9 |
| Q3 2019 | 19 | 52 | 39 | 21 | -2 |
| Q4 2019 | 36 | 49 | 46 | 15 | -4 |
| Q1 2020 | 26 | 43 | 58 | 22 | -4 |
| Q2 2020 | 28 | 65 | 40 | 21 | -2 |
| Q3 2020 | 20 | 78 | 39 | 20 | -6 |
| Q4 2020 | 32 | 66 | 53 | 12 | 8 |
| Q1 2021 | 24 | 81 | 53 | 22 | -8 |
| Q2 2021 | 23 | 71 | 49 | 27 | -4 |
| Q3 2021 | 25 | 75 | 48 | 30 | -15 |
| Q4 2021 | 35 | 67 | 49 | 25 | -5 |
| Q1 2022 | 26 | 63 | 59 | 25 | -2 |
Hedge funds changes in Ascendis Pharma A/S stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 32,517,000 | 5,919,000 |
| Q3 2018 | 22,616,000 | 5,234,000 |
| Q4 2018 | 58,071,000 | 29,767,000 |
| Q1 2019 | 230,334,000 | 145,063,000 |
| Q2 2019 | 109,016,000 | 29,530,000 |
| Q3 2019 | 109,092,000 | 18,492,000 |
| Q4 2019 | 101,688,000 | 26,404,000 |
| Q1 2020 | 50,722,000 | 21,791,000 |
| Q2 2020 | 55,336,000 | 17,896,000 |
| Q3 2020 | 37,539,000 | 10,614,000 |
| Q4 2020 | 29,678,000 | 37,243,000 |
| Q1 2021 | 18,142,000 | 18,360,000 |
| Q2 2021 | 15,890,000 | 70,877,000 |
| Q3 2021 | 22,687,000 | 33,051,000 |
| Q4 2021 | 9,618,000 | 12,214,000 |
| Q1 2022 | 48,019,000 | 31,129,000 |